Osaic Holdings’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36K Buy
+117
New +$2.17K ﹤0.01% 7398
2026
Q1
Sell
-83
Closed -$1.98K 8060
2025
Q4
$1.98K Sell
83
-67
-45% -$1.98K ﹤0.01% 7104
2025
Q3
$4.71K Hold
150
﹤0.01% 6783
2025
Q2
$2.92K Hold
150
﹤0.01% 6802
2025
Q1
$2.56K Buy
+150
New +$3.55K ﹤0.01% 6494
2024
Q2
Sell
-4
Closed -$245 7619
2024
Q1
$245 Buy
+4
New +$281 ﹤0.01% 6943
2021
Q3
Sell
-14
Closed -$6K 7310
2021
Q2
$6K Buy
14
+1
+8% +$499 ﹤0.01% 6314
2021
Q1
$8K Buy
+13
New +$9.38K ﹤0.01% 5991

Other funds holding TRIB

Osaic Holdings's TRIB Position: Q2 2026 in Review

Osaic Holdings opened a new position in Trinity Biotech (TRIB) in Q2 2026: 117 shares worth $1.36K. The stake represents ﹤0.01% of the portfolio and ranks #7398 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in TRIB as recently as Q4 2025.

Osaic Holdings first reported a position in TRIB in Q1 2021 and has held it in 8 quarters since. The position peaked at $8K in Q1 2021. 19 funds tracked by Wall St. Rank hold TRIB as of Q2 2026.

  • Osaic Holdings held 117 shares of Trinity Biotech worth $1.36K as of Q2 2026.
  • Trinity Biotech was a new Osaic Holdings position in Q2 2026.
  • Trinity Biotech made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7398 holding.
  • Osaic Holdings first reported a position in Trinity Biotech in Q1 2021 and has held it in 8 quarters since.
  • Osaic Holdings's Trinity Biotech position peaked at $8K in Q1 2021.
  • 19 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.